Researchers at the Karolinska Institutet in Sweden found that amyloid PET imaging led to diagnosis changes in 68% of patients with memory problems, while another study by GE Healthcare showed the modality altered diagnoses in 20% of patients with cognitive impairment. Both studies, presented at the Alzheimer's Association International Conference, suggest that amyloid PET is useful in clarifying uncertain dementia diagnosis and curbing misdiagnoses, said James Hendrix of the Alzheimer's Association.
Studies evaluate amyloid PET in boosting dementia diagnoses
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.